In a remarkable pivot, Athira Pharma has a deal to test a promising breast cancer drug and landed $90 million in upfront ...

A study from Rutgers Cancer Institute researchers in eClinicalMedicine is the first to link ultra-processed foods to reduced ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

Each monthly installment examines an individual aspect of these crucial conversations, including establishing trust, ...

Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, researchers ...

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the ...

A growing body of evidence suggests GLP-1 receptor agonists may improve survival as well as reduce chemotherapy-related toxicities in women with breast cancer.

Preliminary Phase 2 data demonstrate PCS6422+Capecitabine increased cancer-killing metabolite exposure while maintaining comparable safety to monotherapy capecitabine VERO BEACH, Fla., Dec. 17, 2025 ...

"There's indeed overwhelming evidence that consuming alcohol is associated with an increased risk [of breast cancer]," said ...

Breast cancer in young women is driven by more aggressive molecular and epidemiologic features and requires age-specific, multidisciplinary management that balances oncologic goals with fertility ...

Danielle Fishel said she is feeling positive about her health while speaking exclusively with PEOPLE at iHeartRadio's 102.7 ...

Boy Meets World alum Danielle Fishel is in high spirits nearly one year after completing treatment for breast cancer. “I’m ...